Avid Bioservices (CDMO) Appoints Esther M. Alegria to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
Go back to Avid Bioservices (CDMO) Appoints Esther M. Alegria to its Board
July 1, 2021 6:26 AM EDT
Stephens analyst Jacob Johnson raised the price target on Avid Bioservices (NASDAQ: CDMO) to $29.00 (from $26.00) while maintaining a Overweight rating.... More
June 30, 2021 8:49 AM EDT
Craig-Hallum analyst Matthew Hewitt raised the price target on Avid Bioservices (NASDAQ: CDMO) to $29.00 (from $21.00) while maintaining a Buy rating.
The analyst commented, "With the stock hitting 52-week highs, expectations were high going into Avids Q4 earnings report, but in our... More
June 30, 2021 6:12 AM EDT
RBC Capital analyst Sean Dodge raised the price target on Avid Bioservices (NASDAQ: CDMO) to $27.00 (from $21.00) while maintaining a Outperform rating.... More
June 30, 2021 4:40 AM EDT
KeyBanc analyst Paul Knight raised the price target on Avid Bioservices (NASDAQ: CDMO) to $28.00 (from $22.00) while maintaining a Overweight rating.... More
June 29, 2021 4:11 PM EDT
Avid Bioservices (NASDAQ: CDMO) reported Q4 EPS of ($0.04), versus ($0.11) reported last year. Revenue for the quarter came in at $27.6 million versus the consensus estimate of $21.6 million.
GUIDANCE:
Avid Bioservices sees FY2021 revenue of $115-117 million, versus the consensus of $89.9... More
